Note 7 - Stockholders' Equity

6 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Equity [Text Block]

NOTE 7.  STOCKHOLDERS’ EQUITY

Common Stock. There was no common stock activity during the six months ended March 31, 2024.

Stock Options. There was no stock option activity during the six months ended March 31, 2024.

Stock option details are as follows:

					Weighted
			Weighted		Average
			Average		Contractual		Aggregate
	Number of		Exercise		Term		Intrinsic
	Shares		Price		(Years)		Value
Exercisable at September 30, 2023		1,700,000	$	1.94		3.4	$	-
Outstanding as of March 31, 2024		1,700,000	$	1.94		2.9	$	-
Vested and expected to vest at March 31, 2024		1,700,000	$	1.94		2.9	$	-
Exercisable at March 31, 2024		1,700,000	$	1.94		2.9	$	-

Stock option-based compensation expense associated with stock options was $0 for the six months ended March 31, 2024 and 2023.

Warrants. Warrant activity as of and for the six months ended March 31, 2024 is as follows:

					Weighted
			Weighted		Average
			Average		Contractual		Aggregate
	Number of		Exercise		Term		Intrinsic
	Shares		Price		(Years)		Value
Outstanding as of September 30, 2023		2,148,000		1.33		1.13	$	-
Outstanding as of March 31, 2024		2,148,000		1.33		0.63	$	-
Exercisable at March 31, 2024		2,148,000		1.33		0.63	$	-